4 results
Approved WMORecruiting
Primary objective:• To assess the safety and feasibility of adding ipilimumab-nivolumab to a CRT induction protocol• To assess the efficacy of adding ipilimumab-nivolumab to CRT on the likelihood of a pCR and MPRSecondary objectives: • Local and…
Approved WMORecruiting
Primary objectiveTo determine the pathological complete response rate per cohort
Approved WMORecruiting
Primary Objectives - To compare Overall Survival (OS) and Progression free survival (PFS) of nivolumab monotherapy to ipilimumab monotherapy and that of nivolumab combined with ipilimumab to ipilimumab monotherapy in subjects with previously…
Approved WMORecruiting
To determine safety and efficacy of low molecular weight dextran sulphate during islet transplantation